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2 Expression of bone morphogenetic protein 2, 4, 5, and 7 correlates
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4 PÉTER CSOMOR1, BALÁZS LIKTOR2, BÁLINT LIKTOR2, ZOLTÁN SZEKANECZ3,
5 ISTVÁN SZIKLAI1 & TAMÁS KAROSI1
6 1Department of Otolaryngology and Head and Neck Surgery, Medical and Health Science Center, University of Debrecen,
7 Debrecen, 2Department of Otolaryngology, Bajcsy-Zsilinszky Hospital, Budapest and 3Department of Rheumatology,
AQ38 Medical and Health Science Center, University of Debrecen, Debrecen, Hungary
9 Abstract
10 Conclusion: This study is the ﬁrst to establish that bone morphogenetic protein 5 (BMP5) plays a role in the pathogenesis of
11 otosclerosis. These results conﬁrm that elevated expression levels of BMPs, members of the transforming growth factor
12 (TGF)-b superfamily, contribute to the pathologically increased bone turnover in early, active stages of otosclerosis.Objectives:
13 Otosclerosis is a complex bone remodeling disorder of the otic capsule, which might be characterized by increased expression
14 of different types of BMPs. TGF-b and BMP are both members of the TGF-b superfamily and play a critical role in bone
15 resorption and new bone formation. It has been suggested that BMP and its receptors may be involved in the pathologically
16 increased bone turnover observed in otosclerosis. Methods: Fifty-one otosclerotic and 16 non-otosclerotic ankylotic stapes
17 footplates were histologically analyzed: conventional hematoxylin-eosin staining and BMP2, 4, 5, and 7speciﬁc immunoﬂu-
18 orescent assays were performed. Cortical bone fragments (n = 35) and incus specimens (n = 6) were used as negative controls.
19 Results: Active otosclerosis (n = 39) was characterized by increased expression of BMP2, 4, 5, and 7. Inactive cases of
20 otosclerosis (n = 12) were characterized by negative immunoreaction for BMPs. Non-otosclerotic stapes specimens (n = 16)
21 and negative controls (n = 41) showed negligible BMP expression. The BMP expression pattern showed a strong correlation
22 with the histological activity of otosclerosis.
23 Keywords: Bone remodeling disorder, non-otosclerotic stapes ﬁxation, stapes
24 Introduction
25 Otosclerosis is a primary disorder of bone remodeling
26 unique to the human otic capsule and is characterized
27 by disturbed equilibrium of bone resorption and new
28 bone formation [1,2]. Otosclerotic foci usually appear
29 in the stapes footplate and in the pericochlear region
30 and lead to progressive conductive and/or sensorineu-
31 ral hearing loss as a consequence of stapes footplate
32 ﬁxation and pericochlear bone resorption [1]. The
33 ﬁssula ante fenestram often contains ﬁbrous tissue
34 and immature cartilage and it is a preformed anatomic
35 structure with a predilection for both stapedial and
36 cochlear otosclerosis [1].Otosclerosis is strictly limited
37to the human otic capsule: no otosclerosis-like bone
38lesions have been reported outside of the ear [1,3].
39Otosclerosis is a relatively common cause of hearing
40impairment in the Caucasian white population, with a
41prevalence of 0.3–0.4% [1]. Histological otosclerosis
42is much more common and it has been reported to
43have a prevalence of 8–11% in large unselected
44autopsy series [3]. According to previous reports,
45otosclerosis represents approximately 60% of stapes
46ankylosis cases leading to conductive hearing loss
47[1,4]. Several hypotheses suggested viral, inﬂamma-
48tory, autoimmune, metabolic, and genetic factors as
49possible links to otosclerosis; however, the etiopatho-
50genesis has remained unexplained [1,5,6].
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51 Several genetic predisposition factors for otoscle-
52 rosis have been reported over recent decades [1,6].
53 According to linkage studies, familial aggregation of
54 patients with stapes ﬁxation typically shows an
55 autosomal dominant inheritance with incomplete
56 penetrance and has promoted the identiﬁcation of
57 10 otosclerosis-associated loci (OTSC1–10) [1,6].
58 These loci have been mapped and linked to otoscle-
59 rosis; however, speciﬁc genes and proteins have not
60 been identiﬁed yet [1,6]. In most patients, otosclero-
61 sis does not follow a regular Mendelian segregation,
62 suggesting a complex disease caused by intercon-
63 nected environmental and genetic factors [1,6]. It
64 has been discussed that A1 and A2 alleles of type
65 I collagen (COL1A1/A2), different types of bone
66 morphogenetic protein (BMP2, 4, 7), transforming
67 growth factor-b1 (TGF-b1), CD46-type measles
68 virus receptor, and RELN genes may also be involved
69 in the development of otosclerosis [7–11]. However,
70 some of these genetic associations cannot explain
71 female dominancy, adult onset, and organ-limited
72 pattern of otosclerosis [1,6,7,11].
73 In the last 5 years, BMPs and their receptors
74 (BMPRs) have been reported to contribute to the
75 pathogenesis of otosclerosis [8,12]. BMPs are a group
76 of growth factors and belong to the TGF-b super-
77 family, so they also act as inﬂammatory cytokines
78 [13,14]. At present, 20 distinct isoforms of BMP
79 have been discovered; however, only 6 (BMPs 2–7)
80 function as bone-speciﬁc growth factors [13,14].
81 BMP1 is not closely related to other known growth
82 factors, since it is a matrix metalloproteinase [13,14].
83 BMPs 2–7 play an important role in the embryonic
84 phase of endochondral bone development and later
85 in new bone formation and repair [13,14]. BMPs
86 2–7 are excreted by embryonic chondrocytes, osteoid
87 precursor cells, preosteoclasts, and inﬂammatory T cells
88 [13,14]. Physiologically, BMPs act as disulﬁde-
89 linked homodimers and induce bone and cartilage
90 formation through their receptors [12-14]. Signal
91 transduction process mediated by activated BMPRs
92 results in mobilization and recruitment of SA (Sma
93 and Mad related proteins) proteins [13,14]. Finally,
94 SA induces the expression of TGF-b1 [14]. BMPs
95 and TGF-b1 are critical regulators of bone turnover
96 within the TGF-b superfamily [13,14]. In addition,
97 an inverse interplay has been conﬁrmed between
98 BMP and TGF-b1 pathways [13,14]. Disruption of
99 BMP signaling and mutations in BMPs and in their
100 inhibitors (noggin, chordin, sclerotisin) are associated
101 with a variety of bone diseases, including ﬁbrody-
102 splasia ossiﬁcans progressiva and congenital stapes
103 ﬁxation with multiple synostoses-synphalangism syn-
104 drome [14,15]. Detection of increased BMP expres-
105 sion in otosclerosis might support the ‘embryonic
106cartilage reactivation hypothesis’ in the pathogenesis
107of disease.
108This study investigated the expression levels and
109patterns of different types of BMPs in otosclerotic and
110non-otosclerotic stapes footplates to elucidate the
111effective role of BMP association in the pathogenesis
112of otosclerosis.
113Material and methods
114Patients and controls
115A total of 67 ankylotic stapes footplates (n = 67,
116male = 26, female = 41) removed by stapedectomy
117were analyzed.Themeanageofpatientswas42.28years
118(range 25–65 years). The diagnosis of ossicular chain
119ﬁxation was based on clinical, audiometric, and tym-
120panometric ﬁndings. Air–bone gap at 1000 Hz was
121at least 30 dB on pure tone audiometry. Preoperative
122tympanometry revealed type As tympanograms in
12379.1% (n = 53) and type A tympanograms in 20.9%
124(n = 14) of stapes ﬁxation cases. Stapes ﬁxation was
125clinically bilateral in 44 patients (65.7%); however, only
126one stapes obtained from each patient was analyzed,
127because over this period, only unilateral stapes surgeries
128have been performed. Partially removed stapes foot-
129plates were not included in the study, because the
130anterior or posterior poles containing the bone lesions
131ﬁxing the stapeswere retained in the ovalwindowniche.
132Fragmented and reconstructed footplates were not
133excluded.Thirty-ﬁve cortical bone fragments harvested
134from the external ear canal during lateral atticotomy
135(n = 35) and six incus specimens removed during canal-
136wall-down (CWD)mastoidectomy were used as tissue-
137speciﬁc controls ofBMPexpressionof stapes footplates.
138Cortical bones were obtained from patients with
139stapes ankylosis, while incus specimens originated
140from patients with middle ear cholesteatoma. Stapes
141footplates and control tissue specimens were collected
142from December 2009 until March 2011 (University
143of Debrecen, Medical and Health Science Center,
144Department of Otolaryngology and Head and Neck
145Surgery, Debrecen, Hungary; and ENT Department
146of Bajcsy-Zsilinszky Hospital, Budapest, Hungary). All
147patients gave their informed written consent to our
148study. The Hungarian Scientiﬁc Research Ethical
149Committee (ETT-TUKEB 84-227/2008-1018EKU)
150approved this study. The study was carried out accord-
151ing to the Declaration of Helsinki.
152BMP 2, 4, and 7 speciﬁc immunoﬂuorescent assay
153A total of 67 ankylotic stapes footplates, cortical bone
154fragments (n = 35), and incus samples (n = 6) were
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155 ﬁxed in 10% (w/v) buffered formaldehyde and dec-
156 alciﬁed in 0.5 M Na-EDTA (sodium ethylene-
157 diamino-tetraacetate, 72 h, 4C) containing 0.02%
158 (w/v) sodium azide. Then specimens were embedded
159 in 15% (w/v) puriﬁed gelatin (24 h, 56C) and reﬁxed
160 in 4% (w/v) paraformaldehyde (24 h, 20C). Histo-
161 logical blocks were cryoprotected in 20% (w/v) sac-
162 charose solution (2 h, 4C) and sectioned into 10 mm
163 slides at 25C (MNT-200, Slee, Mainz, Germany).
164 Slides were stored in 0.1 M PBS (phosphate-buffered
165 saline) containing 0.03% (w/v) sodium azide at 4C.
166 Five consecutive 10 mm frozen cut sections were
167 examined as follows. (1) Staining with hematoxylin
168 and eosin (H&E); and (2) BMP2, (3) BMP4, (4)
169 BMP5, and (5) BMP7 speciﬁc immunoﬂuorescent
170 assays (IFAs). First, sections of each individual speci-
171 men were processed by conventional H&E staining.
172 The IFA series of sections were washed and protein
173 blocked in Power Block Reagent (BG-BS-1310-25,
174 Biogenex, Fremont, CA, USA). Blocked sections
175 were incubated with 1:20 monoclonal mouse anti-
176 human BMP2 primary antibody solution (20C, 24 h,
177 continuous shaking) (RD-MAB2260, R&D Systems,
178 Minneapolis, MN, USA), with 1:20 polyclonal goat
179 anti-human BMP2/4 primary antibody solution
180 (20C, 24 h, continuous shaking) (RD-AF355,
181 R&D Systems), with 1:20 polyclonal goat anti-
182 human BMP5 primary antibody solution (20C,
183 24 h, continuous shaking) (RD-AF615, R&D Sys-
184 tems), and ﬁnally with 1:20 monoclonal mouse anti-
185 human BMP7 primary antibody solution (20C, 24 h,
186 continuous shaking) (RD-MAB3542, R&D Systems).
187 Primary antibodies were washed with 0.2 M PBS and
188 sections were incubated with 1:200 Northern Lights
189 donkey anti-goat IgG labeled byNL-493 ﬂuorochrome
190 (20C, 6 h, continuous shaking) (R&D Systems) and
191 with 1:200 Northern Lights donkey anti-mouse IgG
192 labeled by NL-637 ﬂuorochrome (20C, 6 h, contin-
193 uous shaking) (R&D Systems), respectively. All anti-
194 body incubations were performed in a sterile humid
195 chamber. Slides were covered by UV transparent
196 mounting medium (Vectashield, Vector Laborato-
197 ries, CA, USA). Imaging was performed under
198 UV light with 510 nm and 470 nm wavelengths
199 and 43–77 ms exposure time and the photographs
200 were archived in jpeg ﬁle format (Axioskop2 MOT,
201 Axiovision 3.0, Zeiss, Jena, Germany). Individual
202 specimens were analyzed as 10–20 centrally focused,
203 high magniﬁcation ( 40) ﬁelds according to the
204 BMP2, 4, 5, and 7 speciﬁc immunoﬂuorescent reac-
205 tions. Histological examinations were blinded for two
206 independent researchers: P.C. analyzed the sections
207 stained by H&E, while T.K. interpreted the IFAs.
208 The histopathological activity of otosclerosis was
209 based on the cellularity and the structure of cement
210lines by conventional H&E staining. Since otoscle-
211rosis is a multifocal disease, the histopathological
212activity of a stapedial osteolytic focus is not in full
213correspondence with the clinical activity of otoscle-
214rosis [1,4]. We used the following histopathological
215criteria for the diagnosis of otosclerosis. (1) Active
216otosclerosis is displayed by wide pseudo-vascular
A1
B1 B2
C1 C2
D1 D2
E1 E2
BMP2
BMP4
BMP5
BMP7
H&E H&E
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250 µm 
100 µm 
100 µm 
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Figure 1. Immunoﬂuorescent demonstration of BMP expression in
active otosclerosis. (A1) Active focus of otosclerosis with hypercel-
lular osteoid substance and several pseudo-vascular spaces (white
arrow) (H&E, right ear). (A2) Phase-contrast (PC) microscopic
view of the previous section. The cement lines show an irregular
concentric (white arrow) and woven (black arrow) pattern. Immu-
noﬂuorescent micrographs with different magniﬁcation views
for BMP2 (B1, B2), BMP4 (C1, C2), BMP5 (D1, D2), and
BMP7 (E1, E2) display intense granular cytoplasmic immunoreac-
tions in the lesion-forming cells.
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217 spaces ﬁlled with increased numbers of large, mis-
218 shapen, and multinucleate osteoclasts. Cement lines
219 show a woven pattern. (2) Inactive otosclerosis is
220 marked by obliterated vascular spaces and resorption
221 lacunae with decreased numbers of osteoclasts (empty
222 halo cells). Cement lines show a lamellar pattern.
223 Results
224 Ankylotic stapes footplates (n = 67), cortical bone frag-
225 ments (n = 35), and incus specimens (n = 6) were
226 analyzed by BMP2, 4, 5 and 7 speciﬁc IFAs and by
227 conventional H&E staining, respectively. Histological
228 diagnosis of otosclerosis was established in 51 ankylotic
229 stapes footplates (Figures 1 and 2, Table I). Stapes
230 footplates were involved by single and dominant
231 otosclerotic foci. Among these specimens, foci of
232otosclerosis were considered to be active in 39 stapes
233footplates and inactive in 12 cases (Figures 1 and 2,
234Table I). The localization of otosclerotic foci differed
235among the 51 patients withmanifest involvement of the
236stapedial footplate by otosclerosis at the anterior pole
237(n = 31), posterior pole (n = 7), bipolar (n = 6) or
238obliteration (n = 7). In the 16 non-otosclerotic stapes
239footplates, histologic examinations revealed annular,
240stapediovestibular calciﬁcation with marked thickening
241of the stapes footplate [4] (Figure 3,Table I).According
242to the clinical history and otoscopic ﬁndings of non-
243otosclerotic patients, tympanosclerosis due to chronic
244otitismediaorfamiliarstapesﬁxationcouldbeexcluded.
245Active otosclerosis caseswere characterized by simul-
246taneously increased expression of BMP2, 4, 5, and 7
247that resulted in intense granular immunoreaction
248(Figure 1). Both osteoclasts and osteoblasts showed
249considerable positivity for different types of BMPs,
A1
B C
D E
H&E
BMP2 BMP4
BMP5 BMP7
H&E
PC
A2
200 µm 400 µm 
250 µm 
250 µm 
250 µm 
250 µm 
Figure 2. Immunoﬂuorescent demonstration of BMP expression in inactive otosclerosis. (A1) Inactive otosclerotic focus at the posterior pole
of the stapes footplate (H&E, right ear). The lesion is characterized by hypocellularity and empty cellular halos. (A2) Phase-contrast (PC)
microscopic view of the previous section. Cement lines show lamellar pattern (white arrow). The remnants of osteoblasts and osteoclasts
(empty halo cells) show negative immunoﬂuorescent staining for BMP2 (B), BMP4 (C), BMP5 (D), and BMP7 (E).
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250 indicating active bone remodeling and new bone for-
251 mation within the lesion (Figure 1). The BMP immu-
252 noreactivity varied between different parts of the stapes
253 samples. The superstructures were negative for BMPs,
254 while the footplates containing the lesion and the hya-
255 line cartilage layer of the vestibular surface displayed
256 very similar expression patterns. The optimal exposure
257 time was 43 ms for BMP-expressing otosclerotic speci-
258 mens that were strongly positive by IFA. In BMP-
259 negative samples (non-otosclerotic stapes footplates,
260 control bone specimens), exposure time was extended
261 until 77ms toavoid false-negative results. In contrast, in
262 inactive otosclerotic foci, no signiﬁcant BMP expres-
263 sion could be demonstrated on the surface of cellular
264 remnants (Figure 2). In these cases, expression levels
265 and patterns of BMPs were strongly associated with the
266 histopathological activity of otosclerosis (Table I).Non-
267 otosclerotic stapes ﬁxations displayed negative immu-
268 noreactions for BMPs (Figure 3, Table I). Cortical
269 bones and incus specimens applied as negative controls
270 for stapes ﬁxation displayed negative BMP-speciﬁc
271 immunoreactions (Figure 4, Table I). Finally, expres-
272 sion of different types of BMP was strongly associated
273 with the histologic diagnosis of otosclerosis (Table I).
274 Discussion
275 Although several disease-associated monogenic
276 loci have been mapped and linked to otosclerosis,
277experiments to identify causative genes and their
278proteins have been unsuccessful [1,6]. In addition,
279candidate gene association studies on COL1A1,
280COL1A2, and RELN have generated conﬂicting
281results [7,11]. A notable difference with our study
282is that diagnosis of otosclerosis was based on the
283medical history and audiometric ﬁndings of patients
284with stapes ﬁxation without histopathological analysis
285of the surgically removed stapes footplates [6,9,11].
286It might be explained by the limitations of stapedot-
287omy, which is not a suitable method to obtain stapes
288footplate fragments containing the ﬁxing lesions.
289This study aimed to carry out precise immunohis-
290tological assessement of BMP expression in otosclero-
291tic and non-otosclerotic stapes footplates compared
292to bone-speciﬁc controls. The results shown in this
293report are of value, since only three studies have
294reported a potential association between increased
295BMP expression and otosclerosis [8,12,16]. Further-
296more, we conﬁrmed the observations reported by
297Lehnerdt et al. that suspected BMP2, 4, and 7 as
298real causative agents in the pathogenesis of otoscle-
299rosis [8]. According to our current knowledge, this is
300the ﬁrst study in the literature to evaluate the role of
301BMP5 in the pathogenesis of otosclerosis. The pres-
302ent study indirectly supports the proposition that
303increased expression of BMP2, BMP4, BMP5, and
304BMP7, four members of the TGF-b superfamily, also
305plays a role in the otosclerotic bone remodeling
306disorder.
307It has been suggested that different types of BMP
308and BMPRs may be involved in the pathologically
309increased bone turnover observed in otosclerosis
310[8,12,16]. As pioneers, Lehnerdt et al. have per-
311formed immunohistochemical analysis of BMPs
312and BMPRs in otosclerotic stapes footplates [8].
313Signiﬁcantly increased BMP2, BMP4, and BMP7
314expression was demonstrated within the otosclerotic
315foci compared with normal and non-otosclerotic
316bone specimens [8]. Among BMPRs, BMPR-1B
317and BMPR-2 showed increased immunoreactivity,
318whereas BMPR-1A always exerted negative reaction
319[12]. Thus, the effects of BMPs may be mediated
320through type 1B and type 2 BMPRs in otosclerosis
321[12]. Later, the same group carried out immunoﬂu-
322orescent typing of different BMP isoforms in active
323otosclerotic tissues. Again, consequent expressions of
324BMP2, BMP4, and BMP7 were demonstrated [12].
325Schrauwen et al. have reported the potential role of
326various BMP isoforms in the risk of otosclerosis [16].
327There was a signiﬁcant association between clinical
328otosclerosis and the increased expression of BMP2
329and BMP4 [16]. Authors have reported two
330otosclerosis-associated single nucleotide polymorph-
331isms (SNPs) in the genes of BMP2 and BMP4 [16].
Table I. Assessment of expression of bone morphogenetic proteins
(BMPs) 2, 4, 5, and 7 in ankylotic stapes footplates with different
histopathologies and in controls.
Histopathology
(H&E) (n = 108)
BMP2 BMP4 BMP5 BMP7
Otosclerosis (n = 51)
Active focus (n = 39) +++ ++++ +++ +++
Inactive focus
(n = 12)
– + – –
Non-otosclerotic
stapes ﬁxation
(n = 16)
Annular calciﬁcation
(n = 16)
– – – –
Controls (n = 41)
Cortical bone
(n = 35)
– – – –
Incus (n = 6) – – – –
Subjective intensity assessment of immunoﬂuorescence assays
(IFAs) by the analysis of 10 centrally focused magniﬁcation ﬁelds
( 40): +, weak annular immunoreactivity; ++, weak homogeneous
immunoreactivity; +++, strong homogeneous or weak granular
immunoreactivity; ++++, strong conﬂuent and robust granular
reaction.
Expression of BMP in AQ2otosclerosis 5
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332 The ﬁrst non-coding SNP, rs3178250 (BMP2), was
333 located in a 3’ untranslated region, while the second,
334 rs17563 (BMP4), led to amino acid exchange in
335 BMP4 that was strongly associated with otosclerosis
336 [16]. These observations are reasonable to assume,
337 since both BMPs and TGF-b are key regulators of
338 new bone formation. In addition, there are several
339 interconnected events in the BMP and TGF-b path-
340 ways that result in inverse interactions between the
341 two protein groups [17,18].
342 In the embryonic phase and in the early postnatal
343 period, a regular enchondral ossiﬁcation develops in
344 the otic capsule and in the stapes footplate, which is
345 completed after 1 year [1]. Osteoblastic and osteo-
346 clastic activity, normally associated with bone turn-
347 over, is rarely, if ever, seen in the adult otic capsule
348 [1,2]. There is a potential explanation for this phe-
349 nomenon: low-grade bone turnover protects the
350 membranous labyrinth and the organ of Corti from
351serious biomechanical changes during life [1,2]. The
352otic capsule is formed by three bone-like layers, i.e.
353the endosteal layer next to the perilymphatic space,
354the interosseal globules (globuli inerossei), which are
355embryonic cartilage remnants, and the periosteal layer
356[1]. The enchondral layer of the otic capsule contains
357peculiar, embryonic chondrocytes, which persist
358throughout life [1,19]. Similar cells can be found in
359the vestibular layer of the stapes footplate. It has
360been reported that these remnants may be the sites
361of the earliest otosclerotic foci [1,19]. However, these
362cells disappear from otosclerotic foci and are replaced
363by pre-osteoclasts and active osteoclasts [19]. In con-
364trast to normal adult otic capsule, osteoclasts and
365osteoblasts of otosclerotic foci express a special
366embryonic glycoprotein (CD51/61 – osteoclast func-
367tional antigen) [19]. In addition, increased expression
368of BMPs, TGF-b, tumor necrosis factor (TNF)-a,
369and apoptosis inhibitors (hCIAP1/2) also supports
A H&E
B C
D E
BMP2 BMP4
BMP5 BMP7
800 µm 
800 µm 
800 µm 800 µm 
800 µm 
Figure 3. Immunoﬂuorescent demonstration of BMP expression in non-otosclerotic stapes ﬁxation. (A) Non-otosclerotic, annular calciﬁ-
cation of the stapes footplate with hypocellular and angled anterior pole (H&E, right ear). The osteocytes show negative immunoreactions for
BMP2 (B), BMP4 (C), BMP5 (D), and BMP7 (E).
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370 the embryonic chondrocyte reactivation hypothesis
371 in otosclerosis [1,8,9,20]. According to previous
372 reports, chondroblasts and osteoblasts might be reac-
373 tivated and transformed into osteoclasts due to the
374 inﬂammatory response induced by measles virus
375 infection [5,19,20].
376 In conclusion, otosclerosis can be considered as a
377 complex bone remodeling disorder that is inﬂuenced
378 by genetic, environmental, and metabolic factors.
379According to current and previous results, it can be
380suggested that different types of BMPs may play a
381signiﬁcant role in the early molecular events of active
382otosclerosis. In the light of this association, further
383studies are necessary to determine the role of BMP in
384the pathophysiology of otosclerosis to ﬁnd the most
385promising medical (biological) treatment for early
386active stages.
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